Chia Tai Tianqing Pharmaceutical Group Co Ltd, Shouyao Holdings Beijing Co Ltd and Lianyungang Runzhong Pharmaceutical Submit European Patent Application for Use of Pyrrolopyrimidine Compound and Pharmaceutical Composition Thereof for Treating Chronic Graft Versus Host Disease
In: Global IP News (India), 2024-05-13, S. 2
Zeitungsartikel
Zugriff:
Munich, May 13 -- Chia Tai Tianqing Pharmaceutical Group Co Ltd, Shouyao Holdings Beijing Co Ltd and Lianyungang Runzhong Pharmaceutical have submitted a patent application for use of pyrrolopyrimidine compound and pharmaceutical composition thereof for treating chronic graft versus host disease. This invention was developed by Tu Lifan, Zhang Xiquan, Wang Xunqiang, Yu Ding and Huang Jianqiang...
Titel: |
Chia Tai Tianqing Pharmaceutical Group Co Ltd, Shouyao Holdings Beijing Co Ltd and Lianyungang Runzhong Pharmaceutical Submit European Patent Application for Use of Pyrrolopyrimidine Compound and Pharmaceutical Composition Thereof for Treating Chronic Graft Versus Host Disease
|
---|---|
Zeitschrift: | Global IP News (India), 2024-05-13, S. 2 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|